$FHTX
Foghorn Therapeutics Inc
PRICE
$13 โผ-3.846%
Extented Hours
VOLUME
1,102,042
DAY RANGE
11.025 - 12.1
52 WEEK
8.01 - 24.34
Key Metrics
Market Cap
474.81 M
Beta
1.41
Avg. Volume
142.92 K
Shares Outstanding
41.47 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-10
Next Dividend Date
Company Information
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. The Company's proprietary Gene Traffic Controlยฎ platform gives it an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system.
Website: foghorntx.com
HQ: ,
Related News